General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Selenomonas sputigena is a Gram-negative, non-spore-forming, strictly anaerobic, motile, rod-shaped - curved bacterium. It has been detected in at least 5 gut microbiome compilation studies or metastudies. The DNA G+C content is 57%. Selenomonas sputigena is probably a rare gut coloniser. (Shouche2011Bergey)



  • This organism has been recovered from oral flora. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Could be a possible pathogen in humans, but unknown at this stage. A possible gut commensal.

  • GENERAL CHARACTERISTICS (Shouche2011Bergey);
    Character Response
  • Substrates hydrolysed or digested:
  • urea;
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 35-40℃.
  • H+
  • Acid from carbohydrates usually produced:
  • fructose; galactose; glucose; lactose; maltose; melibiose; raffinose; sucrose;
  • ±
  • Strain-dependent acid from carbs:
  • glycerol;
  • Substrates assimilated or utilised:
  • valerate;
  • Active enzymes:
  • α-galactosidase; urease;
  • ±
  • Strain-dependent active enzymes:
  • β-galactosidase; α-glucosidase;

  • SPECIAL FEATURES (Shouche2011Bergey);
    Character Response
  • Metabolites produced:
  • acetate; propionate; succinate (trace); CO₂;
  • Metabolites not produced:
  • lactate; H₂S;
  • ±
  • Nitrate:
  • strain dependent

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Negativicutes Order:  Selenomonadales Family:  Selenomonadaceae Genus:  Selenomonas Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Swimming Morphology:  Rod - curved
    Health:  Unknown
    Source:  oral flora
    DNA G+C(%):  57
    Opt. T:  35-40℃
    Aesculin:  neg Urea:  + Hippurate:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Arabinose:  neg Fructose:  + Galactose:  + Glucose:  + Mannose:  neg Rhamnose:  neg Ribose:  neg Sorbose:  neg Xylose:  neg Cellubiose:  neg Lactose:  + Maltose:  + Melezitose:  neg Melibiose:  + Sucrose:  + Trehalose:  neg Amygdalin:  neg Dextrin:  neg Aesculin:  neg Glycogen:  neg Inulin:  neg Pectin:  neg Xylan:  neg Adonitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  d Inositol:  neg Mannitol:  neg Sorbitol:  neg Salicin:  neg

    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Valerate:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  + Ac-β-glcamnd:  neg α-Fucosidase:  neg α-Galactosidase:  + β-Galactosidase:  d α-Glucosidase:  d β-Glucosidase:  neg ArgDH:  neg Chymotrypsin:  neg GlyAA:  neg LeuGlyAA:  neg PyrrolidAA:  neg PheAA:  neg SerAA:  neg ValAA:  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Acetate:  + Propionate:  + Lactate:  neg Succinate:  trace(+) H2S:  neg CO2:  +

    References


    SPECIFIC REFERENCES FOR SELENOMONAS SPUTIGENA
  • Shouche2011Bergey - Bergey's manual of systematic bacteriology. Vol. 3, The Firmicutes. Family Veillonellaceae, Genus XXI. Selenomonas
  • Yachida2019 - Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR SELENOMONAS SPUTIGENA
  • De2020 - Metagenomic analysis of gut microbiome and resistome of diarrheal fecal samples from Kolkata, India, reveals the core and variable microbiota including signatures of microbial dark matter.
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................